Nabta Health (“NABTA”) has successfully raised $2 million in a Pre-Series A funding round, bringing its total funding to $4.5 million so far.
This new funding will help NABTA speed up its mission of providing accessible and science-backed healthcare for women. It will also support the expansion of its AI-powered hybrid care model across the Middle East and Africa.
The company plans to use the investment to build stronger partnerships with employers, insurance companies, and healthcare providers. It will also introduce new diagnostic options and at-home testing services, while improving its clinical systems in collaboration with top hospitals.
This year, NABTA was featured on TIME Magazine’s list of Top HealthTech Companies for 2025. The company also launched a Women’s Health Centre of Excellence with Clemenceau Medical Center Hospital Dubai and expanded its corporate health programs across the region.
All these achievements show how NABTA is becoming a key innovator in women’s health in the MEA region, offering a mix of online, in-clinic, and community-based care to support women at every stage of life.
Sophie Smith, Founder and CEO, Nabta Health, said: “We are delighted to have closed this Pre-Series A round and to bring our total funding to date to US$4.5 million. This investment validates our vision – that women’s health in the region can be reimagined through an AI-powered, hybrid care model that meets women where they are, respects cultural context and delivers measurable outcomes. We are now looking to accelerate our growth so that more women and employers benefit from what we believe is the future of women-centred health: affordable, mobile-first, and engineered for sovereignty.”
“For employers and insurers in the region, addressing the women’s health gap is not just a moral imperative; it is a business and productivity one,” added Smith. “With this funding, we will drive scale, deepen impact and prepare for the next chapter of growth.”
Iain McMillan, Chair, Nabta Health, said:“The closing of this Pre-Series A round is confirmation that Nabta Health is being increasingly recognised in the region as a key enabler of measurably better women’s health. The business has steadily gained traction and grown its customer base throughout 2025 and I am looking forward to seeing further acceleration in our success as we move forward into 2026 and beyond.
Read more- Tribe Stays raises $2.8 million seed round led by Artha Venture Fund
